---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-411260"
form_type: "8-K"
ticker: "QNCX"
cik: "0001662774"
company_name: "Quince Therapeutics, Inc."
filed_at: "2026-10-02T11:30:27+00:00"
generated_at: "2026-10-12T14:31:04.583219+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Quince Therapeutics board overhaul: 3 directors to resign, 4 named pending Oct 6 vote

## Summary
- Directors June Bray, David Lamond and Christopher Senner conditionally resigned effective two business days after the Oct 6, 2026 Special Meeting; no disagreement with the Company cited.
- Board seats contingent on approval of three proposals: Series C conversion (>20% of shares outstanding), Minimum Price Proposal, and raising authorized shares from 250M to 275M.
- Incoming directors: Catherine Bonuccelli (Class I; Audit, Comp), Leone Patterson (Class III; chair Audit & Comp), James Valentine (Class I; chair NomGov), Drayton Wise (Class II; NomGov).
- Conversion Proposal may, together with certain management and board changes, result in a change of control under Nasdaq Listing Rule 5635(b).
- Incoming directors' backgrounds: Bonuccelli ex-Bellus Health CMO; Patterson ex-CFO Zymeworks and Tenaya; Wise ex-CCO Insmed; Valentine director at Hyman, Phelps & McNamara.

## SEC filing metadata
- accession: 0001193125-26-411260
- form_type: 8-K
- ticker: QNCX
- cik: 0001662774
- company_name: Quince Therapeutics, Inc.
- filed_at: 2026-10-02T11:30:27+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662774/000119312526411260/0001193125-26-411260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526411260/d171747d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-411260
- JSON: https://secwatch.observer/filing/0001193125-26-411260.json
- Plain text: https://secwatch.observer/filing/0001193125-26-411260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.